Rituximab for Children with Immune Thrombocytopenia: A Systematic Review

Immediate Hypersensitivity Reaction and Successful Rapid Desensitization to Rituximab Followed by Serum Sickness in a 4 Year Old

(2011) E. Romanos-Sirakis et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment Results of Children with Chronic Immune Thrombocytopenic Purpura (ITP) Treated with Rituximab

(2010) E. C. Citak et al.   JOURNAL OF TROPICAL PEDIATRICS

The Long-term Impact of Rituximab for Childhood Immune Thrombocytopenia

(2010) Nichola Cooper et al.   Current Rheumatology Reports

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

(2009) K. R. Carson et al.   BLOOD

International consensus report on the investigation and management of primary immune thrombocytopenia

(2009) D. Provan et al.   BLOOD

Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin

(2009) Nichola Cooper et al.   BRITISH JOURNAL OF HAEMATOLOGY

Treatment of chronic immune thrombocytopenic purpura with rituximab in children

(2009) Murat Dogan et al.   INDIAN JOURNAL OF PEDIATRICS

Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura

(2009) Shoko Goto et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)

(2009) V. Koneti Rao et al.   PEDIATRIC BLOOD & CANCER

PERSISTENT ANTIBODY DEPLETION AFTER RITUXIMAB IN THREE CHILDREN WITH AUTOIMMUNE CYTOPENIAS

(2009) Mehdi Mohammad G. Adeli et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group

(2008) F. Rodeghiero et al.   BLOOD

Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response

(2008) Emilia Parodi et al.   BRITISH JOURNAL OF HAEMATOLOGY

B-Cell Depletion for Autoimmune Thrombocytopenia and Autoimmune Hemolytic Anemia in Pediatric Systemic Lupus Erythematosus

(2008) S. Kumar et al.   PEDIATRICS

Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias

(2007) Aarati Rao et al.   PEDIATRIC BLOOD & CANCER